HLS Therapeutics Inc.

HLTRF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$4-$3-$4-$3
Dep. & Amort.$6$5$5$5
Deferred Tax-$0-$0-$0$0
Stock-Based Comp.$1$0$1$0
Change in WC-$1$1$2-$0
Other Non-Cash$1$0$0$0
Operating Cash Flow$2$5$4$3
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0-$1$0$0
Investing Cash Flow-$0-$1-$0-$0
Financing Activities
Debt Repay.-$1-$9-$3-$3
Stock Issued$0$0$0$0
Stock Repurch.-$1-$1-$0-$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1$0$0-$0
Financing Cash Flow-$3-$9-$3-$3
Forex Effect-$0$0$0-$1
Net Chg. in Cash-$1-$6$0-$0
Supplemental Information
Beg. Cash$12$18$17$18
End Cash$11$12$18$17
Free Cash Flow$2$4$4$3